Prognostic factors among elderly patients with operable non-metastatic breast cancer treated with primary endocrine therapy

被引:0
|
作者
Rocha, Erika Andrade
Vasconcellos, Jessica Monteiro
Mendes, Sofia Vidaurre
Freire, Pedro Jose Galvao
Messias, Ana Paula
Leis, Leticia Vecchi
Moreira, Otavio Noschang
Pereira, Mauricio Baptista
Orsi, Bruna Zanin
Araujo Neto, Augusto
Petry, Vanessa
Bonadio, Renata Colombo
Testa, Laura
机构
关键词
D O I
10.1158/1538-7445.SABCS22-P4-07-32
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P4-07-32
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Survival in patients with non-metastatic breast cancer treated with adjuvant trastuzumab in clinical practice
    Gallagher, Christopher M.
    More, Kenneth
    Masaquel, Anthony
    Kamath, Tripthi
    Guerin, Annie
    Ionescu-Ittu, Raluca
    Nitulescu, Roy
    Gauthier-Loiselle, Marjolaine
    Sicignano, Nicholas
    Butts, Elizabeth
    Wu, Eric Q.
    Barnett, Brian
    SPRINGERPLUS, 2016, 5
  • [42] Prevalence of non-metastatic breast cancer patients treated with aromatase inhibitors in the United States
    Liede, A.
    Hernandez, R. K.
    Pirolli, M.
    Quigley, J.
    Quach, D.
    CANCER RESEARCH, 2012, 72
  • [43] Prognostic Value of Platelet Counts in Patients with Metastatic Prostate Cancer Treated with Endocrine Therapy
    Shimodaira, Kenji
    Nakashima, Jun
    Nakagami, Yoshihiro
    Hirasawa, Yosuke
    Hashimoto, Takeshi
    Satake, Naoya
    Gondo, Tatsuo
    Namiki, Kazunori
    Ohori, Makoto
    Ohno, Yoshio
    UROLOGY JOURNAL, 2020, 17 (01) : 36 - 41
  • [44] Clinical prognostic and predictive factors for primary chemotherapy in operable breast cancer
    Ellis, P
    Smith, I
    Ashley, S
    Walsh, G
    Ebbs, S
    Baum, M
    Sacks, N
    McKinna, J
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (01) : 107 - 114
  • [45] Different survival determinants of metastatic breast cancer patients treated with endocrine therapy or chemo-endocrine therapy
    Nomura, Y
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1998, 12 (04) : 817 - 824
  • [46] Knowledge of Cancer Stage Among Women With Non-Metastatic Breast Cancer
    Hinchey, Jenna
    Goldberg, Jessica
    Linsky, Sarah
    Linsky, Rebecca
    Schulman-Green, Dena
    NURSING RESEARCH, 2013, 62 (02) : E75 - E76
  • [47] Prognostic Factors for Locoregional Recurrence in Operable Breast Cancer Patients Treated with Preoperative Systemic Chemotherapy
    Jung, S-Y
    Min, S. Y.
    Lee, S. J.
    Park, C.
    Kwon, Y.
    Kim, E-A
    Ko, K. L.
    Lee, K. S.
    Park, I. H.
    Jeong, J.
    Shin, K. H.
    Lee, S.
    Kim, S. W.
    Kang, H-S
    Ro, J.
    CANCER RESEARCH, 2009, 69 (24) : 569S - 569S
  • [48] A comparison of survival rates in elderly breast cancer patients treated with surgery or primary endocrine therapy with aromatase inhibitors
    Morrow, E. S.
    Lannigan, A.
    Stallard, S.
    Mallon, E.
    Doughty, J.
    Romics, L.
    BRITISH JOURNAL OF SURGERY, 2017, 104 : 44 - 44
  • [49] Neoadjuvant Therapy in Non-Metastatic Breast Cancer in Kurdistan, Iraq
    Namiq, K.
    Sulaiman, L.
    BREAST, 2023, 68 : S67 - S67
  • [50] Is the difference between tamoxifen and anastrozole in adjuvant trials applicable for primary endocrine therapy of early operable primary breast cancer in the elderly?
    Agrawal, A.
    Ying, M.
    Winterbottom, L.
    Morgan, D. A. L.
    Ellis, I. O.
    Cheung, K. L.
    EJC SUPPLEMENTS, 2007, 5 (03): : 11 - 11